SeaCrest Wealth Management’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
Other funds holding SNY
DC
QCM
MFG
TNB
SIS
FBT
FB
CAMG
SeaCrest Wealth Management's SNY Position: Q2 2026 in Review
SeaCrest Wealth Management increased its Sanofi (SNY) stake by 6% in Q2 2026, buying an estimated $13.8K and bringing the position to 5,475 shares worth $234K. The position accounts for 0.03% of the portfolio, ranked #480.
SeaCrest Wealth Management first reported a position in SNY in Q4 2017 and has held it in 30 quarters since. The position peaked at $935K in Q3 2020. 108 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- SeaCrest Wealth Management held 5,475 shares of Sanofi worth $234K as of Q2 2026.
- SeaCrest Wealth Management bought 308 Sanofi shares in Q2 2026, an estimated $13.8K.
- Sanofi made up 0.03% of SeaCrest Wealth Management's portfolio in Q2 2026, its #480 holding.
- SeaCrest Wealth Management first reported a position in Sanofi in Q4 2017 and has held it in 30 quarters since.
- SeaCrest Wealth Management's Sanofi position peaked at $935K in Q3 2020.
- 108 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.